Chronic Lyme disease

What do people mean by "chronic Lyme disease"?

The phrase gets used for at least two very different situations, and much of the conflict around this diagnosis comes from blurring them together. A widely cited review in the New England Journal of Medicine (Feder et al., 2007) mapped the territory. Some people carrying a "chronic Lyme" diagnosis have persistent symptoms after documented, treated Lyme disease. Many others have never had laboratory or clinical evidence of Lyme infection at all, and received the label for symptoms like fatigue, widespread pain, and brain fog that have a long list of possible causes.

• Post-treatment Lyme disease syndrome (PTLDS). You had documented Lyme disease, you completed appropriate antibiotics, and the infection responded. Months later you are still exhausted, in pain, or mentally foggy. This is a recognized, researched condition.
• "Chronic Lyme" without confirmed infection. Persistent symptoms attributed to Lyme disease in someone with no reliable evidence of ever having been infected, often on the basis of unvalidated tests. The symptoms are real. The explanation is not supported, and it can steer people away from finding what is actually going on.

This page uses PTLDS for the documented version, because that is where the science is. Everything here about validation, mechanisms, and what helps applies to anyone whose symptoms have been dismissed. A dismissed symptom is still a symptom.

What is post-treatment Lyme disease syndrome?

PTLDS describes a recognizable cluster of profound fatigue, musculoskeletal pain, and cognitive difficulty ("brain fog") that persists for six months or longer after appropriate antibiotic treatment for documented Lyme disease and interferes with daily life. Sleep problems, headaches, and joint aches are common companions.

It is not rare. The CDC estimates that about 5–10% of people treated for Lyme disease have prolonged symptoms. A prospective Johns Hopkins cohort study went further. Even among patients whose early Lyme disease was diagnosed promptly and treated ideally with three weeks of doxycycline, about 14% met criteria for post-treatment Lyme disease, versus about 4% of comparison participants without Lyme. That suggests the illness itself, rather than inadequate treatment, sets some people up for persistent symptoms.

Two features of PTLDS matter for everything that follows. First, studies using the best available microbiologic tools have generally not found evidence of ongoing live infection in people with PTLDS. Second, its symptom profile overlaps strikingly with fibromyalgia, chronic fatigue syndrome, and long COVID, all conditions where a triggering event leaves the nervous and immune systems stuck in a protective state after the trigger has passed.

Do more antibiotics help? What the retreatment trials found

This is the best-studied question in the field, and the answer is unusually clear. The U.S. National Institutes of Health funded four randomized, placebo-controlled trials of prolonged or repeated antibiotics for persistent symptoms after treated Lyme disease. That is the strongest study design medicine has.

The harms were not theoretical. Across these trials and in case reports since, prolonged antibiotic therapy, intravenous therapy especially, has caused bloodstream infections from IV catheters, gallbladder disease, severe allergic reactions, and Clostridioides difficile colitis. The CDC has documented serious injury and death from long-term "chronic Lyme" antibiotic regimens. On the strength of this evidence, the 2020 IDSA/AAN/ACR guideline recommends against additional prolonged antibiotic courses for post-treatment symptoms.

So why do symptoms persist after the infection is treated?

Honest answer: researchers do not fully know, and anyone claiming certainty in either direction is ahead of the evidence. Several mechanisms are under active study, and they are not mutually exclusive:

• Persistent immune activation. In some studies, people with post-treatment symptoms show altered immune markers long after treatment. The infection may leave behind bacterial debris or trigger immune responses that outlast it. This is a leading hypothesis, not an established cause.
• Autoimmune-like processes. Infection can occasionally teach the immune system to react to the body's own tissue. That mechanism is suspected in antibiotic-refractory Lyme arthritis and has been investigated in PTLDS.
• Autonomic nervous system changes. Dysregulation of the system controlling heart rate, blood pressure, and energy has been reported in post-treatment Lyme patients, overlapping with findings in long COVID and chronic fatigue syndrome.
• [Central sensitization](/central-sensitization). A published line of research (Batheja et al., 2013) proposes that the infection and the illness experience can shift the central nervous system into a persistently protective state, amplifying pain, fatigue, and sensory signals even though the original trigger is gone. The overlap between PTLDS and conditions like fibromyalgia is one reason this hypothesis is taken seriously.

That last mechanism matters because it is the one with an established treatment direction. Modern pain science calls it neuroplastic pain: when symptoms are being generated or amplified by an over-protective nervous system, the system can be retrained. That does not require the infection to be "in your head." It requires understanding that all symptoms, whatever starts them, are ultimately produced by the brain and can outlast their original cause.

What about untreated or active Lyme disease?

Everything above concerns symptoms that persist after treatment. Untreated Lyme disease is a different matter entirely: a genuine bacterial infection that can spread to the joints, heart, and nervous system, and that needs antibiotics. Antibiotics work very well against it, especially when started early. See a clinician promptly if you have:

• An expanding rash after a tick bite or time in tick habitat, classically a bull's-eye (erythema migrans), though many are solid-colored. This alone is enough to diagnose and treat Lyme disease.
• Facial droop (facial palsy), a known sign of nervous-system Lyme.
• Palpitations, fainting, chest pain, or breathlessness in the weeks after possible exposure. Lyme carditis can disrupt the heart's rhythm and is a medical emergency.
• A swollen, warm joint, most often the knee, which can be Lyme arthritis.
• Fever, severe headache, or stiff neck after a tick bite, which needs evaluation for Lyme and other tick-borne infections.

If any of these describe you, this page is not your page yet. Evaluation and treatment of the infection come first. The persistent-symptom picture discussed here only applies once the infection has been appropriately treated.

How is it diagnosed, and which tests should you be wary of?

Lyme disease is diagnosed from symptoms, exposure history, and validated two-tier antibody testing, meaning an initial immunoassay followed by a confirmatory test, per CDC and the 2020 IDSA/AAN/ACR guideline. The tests have real limitations (they can miss very early infection, and they stay positive long after cure, so they cannot show whether bacteria are still present), but they are the standard for good reasons.

PTLDS itself has no diagnostic test. It is identified clinically: documented, treated Lyme disease followed by six or more months of characteristic symptoms, with other causes ruled out. That last step matters, because thyroid disease, sleep apnea, anemia, depression, autoimmune disease, and other treatable conditions can produce the same picture and deserve a genuine workup.

A gentle warning about unvalidated testing

A parallel industry offers tests that mainstream laboratories do not use: unvalidated "specialty" Lyme panels with in-house criteria, live-cell microscopy, urine antigen tests, and others. The NEJM critical appraisal and the CDC both warn that these methods have not demonstrated reliable accuracy. Some will return "positive" results in large fractions of healthy people. A diagnosis built on such a test can cost thousands of dollars, delay discovery of the real problem, and lead to years of treatment for an infection that was never there. Before acting on any positive Lyme result, it is fair to ask whether it came from validated two-tier testing.

What actually helps with persistent symptoms?

There is no single proven cure for PTLDS. That is not the same as "nothing helps." The approach with the best evidence and safety profile mirrors modern care for fibromyalgia, chronic fatigue syndrome, and other persistent-symptom conditions:

• A clinician who takes the symptoms seriously. Validation is not a courtesy. Feeling believed reduces the threat load on a nervous system already stuck in high alert.
• Symptom-directed treatment. Sleep problems, headaches, joint pain, low mood, and orthostatic symptoms each have specific, evidence-based treatments, none of which require re-treating the infection.
• Pacing, then graded reactivation. Most people improve over time. Gentle, gradually increasing activity outperforms both pushing through crashes and open-ended rest. Expand it at a rate the nervous system can tolerate, not a rate set by frustration. Our guide to living with chronic pain covers the practical method.
• Retraining an over-protective pain system. To the extent central sensitization contributes, approaches that teach the brain safety target the mechanism directly: pain neuroscience education, graded exposure to feared movement, and the broader toolkit in modern chronic pain treatment. Karuna's program applies this retraining approach to chronic pain generally. It is not a treatment for Lyme disease or PTLDS as such.
• Skepticism toward expensive certainty. Long-term antibiotics, IV "protocols," hyperbaric oxygen, chelation, and similar offerings for chronic Lyme have no reliable supporting evidence and documented harms. A practitioner who is certain, expensive, and outside the evidence is a red flag, however kind.

If your pain has features of an over-protective pain system, such as spreading beyond the original area, flaring with stress, or moving unpredictably, our neuroplastic pain quiz can help you and your clinician think through whether pain-system retraining belongs in your plan.

When should you see a doctor?

Persistent symptoms after Lyme disease always deserve medical attention, both to rule out other treatable causes and to build a symptom-management plan. Seek care promptly if you have:

• Any red flag for active infection: expanding rash, facial droop, heart symptoms, or a hot swollen joint (see above).
• New or worsening neurological signs such as progressive weakness, numbness, vision changes, or confusion, which need evaluation regardless of their cause.
• Unexplained weight loss, fevers, or night sweats, which point away from PTLDS and toward something else.
• Symptoms that are steadily worsening rather than fluctuating or slowly improving. PTLDS typically plateaus and improves, so steady decline warrants a fresh look.
• Mood changes or hopelessness that are becoming hard to carry. Living with a contested, invisible illness is genuinely hard, and support helps.

Whoever you see, you are entitled to a clinician who neither dismisses your symptoms nor sells you certainty. Both kinds are out there. Keep looking until you find someone who is neither, because the difference matters for your health and your wallet alike.